# Faeth Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2026

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: DEF 14A
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 16:19 ET
- Period: 2026-06-10
- Accession: 0001193125-26-182143
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312526182143/d16802ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312526182143/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312526182143/d16802ddef14a.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-182143. Last ingested by Listed: Nov 9, 2026, 18:03 ET. No prices; not investment advice.